PSI - Learning from Fitness to Practise Inquiries (Enbrel) | ICPhA

PSI - Learning from Fitness to Practise Inquiries (Enbrel)

ICPhA.ie is temporarily open to anonymous access. Please REGISTER your own account to ensure continued access.

By signing up, you will also enable additional functionality, such as COMMENTING, SEARCHING, VOTING ON/VIEWING polls and gain ACCESS to the PRIVATE FORUM area.

Register »

We all received the PSI newsletter this morning and with it a shocking case of poor professional practice.

The Professional Conduct Committee (PCC) heard a complaint in which a patient had been supplied with the High Tech medicine Enbrel® (etanercept) 50mg solution for injection, without a valid prescription on multiple occasions over a 14 month period. This contributed to a situation where the patient did not attend clinical review with their Consultant Rheumatologist for over 2 years. This was brought to the attention of the PSI by a HSE primary care pharmacist and the patient’s Consultant Rheumatologist. As a result, the PSI initiated an investigation into the pharmacy, to review the documentation relating to the supply of Enbrel® to this patient, and the general systems that were in place in relation to the dispensing of Enbrel® generally.

  • The Authorised Officer's investigation led to a review of the relevant prescriptions at the pharmacy, which identified that two pharmacists had supplied the patient with Enbrel® 50mg injection after the expiry date of the last prescription issued by the Consultant Rheumatologist.  This resulted in the supply of this medicine on 11 separate occasions over a 14 month period, without a valid prescription or any clinical review.    
  • The Authorised Officer noted that the last valid prescription authorising the supply of Enbrel® 50mg injection for the patient was not endorsed, as required by the legislation.  If this requirement had been followed it would have assisted the pharmacists in identifying that the prescription was not in date and that the patient required a clinical review.
  • During the investigation the Authorised Officer requested to review the prescriptions used to authorise eight supplies of Enbrel® to other patients.  Seven of the eight prescriptions retrieved and presented for review were not endorsed to show the date and quantity of supply to the patient, as required by the legislation.

It is hard to believe that anyone could dispense Enbrel "on 11 separate occasions over a 14 month period, without a valid prescription or any clinical review." While we don't know the exact circumstances of this case, this is a terrible indictment of the Irish community pharmacy. I hope this was an isolated case, otherwise some of us are providing a dangerously poor quality pharmacy service to our patients.

It would also be very interesting to hear the full from the pharmacists involved.

Source: A Complaint Involving the Dispensing of the High Tech Medicine Enbrel® Injection (PSI)

Latest Articles

  • Important COVID-19 resources for healthcare professionals

    With the first case of COVID-19 now confirmed in Ireland it's important to stay abreast of the latest developments. Let's start with some statistics. Incubation period It is widely reported that the incubation period for SARS-CoV-2 is between 2 to 14 days, however there are also reports of up to...
  • Can pharmacies exchange medicines when they have excess stock?

    Can pharmacies exchange medicines when they have excess stock? Managing pharmacy stock in a way that ensures uninterrupted supply to as many patients as possible, while also maintaining manageable stock levels, has always been challenging, but became even more so with the introduction of the 10-day...
  • Centralisation of the Drugs Payment Scheme

    Some of us though this day would never come, but it's official now, the administration of the Drugs Payment Scheme (DPS) is just days away from finally being centralised. Starting on 26th November 2018, you can contact the National Medical Card Unit, PCRS whenever you have an issue relating to the...

Latest News

  • 2019 PSI Council Election Campaigns Have Begun

    As of 2nd April 2019 the ballot papers have been posted out to the electoral register to elect four new pharmacist members to the PSI council for a four year term. The PSI council is made up of 21 members, of which 10 are pharmacist members and 11 are non-pharmacist members. As a profession we are...
  • Facebook Deletes the Largest Irish Pharmacist Group

    Last week, without any warning, Facebook deleted the largest Irish pharmacist group of over 2600 members. This is now being appealed but it is anyone's guess if and when the group will be restored. Given how quickly and unexpectedly this has happened, it would be very prudent to have a backup...
  • No More Paper Based Claims Listings

    In another cost cutting measure, the HSE PCRS will stop posting out physical paper-based claims listings from 1st July 2018. The document will then only be available online via the Pharmacy Application Suite. Small exception has been made for manual claiming pharmacies, which will receive their...
  • LTI Non-Core List Reimbursement to Change in July

    The HSE have signaled that they will reduce the reimbursement period of non-approved non-core LTI items from current 4 months to just 2 months beginning on the 1st of July 2018. This change is being introduced ahead of the promised improved visibility of these individually approved items via the...
  • Can we still use faxes under GDPR?

    It's the eve of GDPR implementation and one of our favourite tools is under threat. A lot of rumors have been going around regarding the use of fax to transfer personal information such as an emergency supply script for example. Well, we're happy to report that you can take a deep breath and relax...